Baxter International | BAX - Trade Creditors

Stock Price
17.30
Daily Change
-0.48 -2.70%
Monthly
-4.63%
Yearly
-45.36%
Q2 Forecast
16.95

Baxter International reported $1.09B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.24B 117M Dec/2025
AngioDynamics USD 35.39M 3.51M Sep/2025
Artivion USD 18.34M 2.3M Mar/2026
AtriCure USD 70.06M 8.34M Mar/2026
Avanos Medical USD 52.3M 3.2M Mar/2026
Baxter International USD 1.09B 87M Mar/2026
Becton, Dickinson and Co. USD 5.93B 204M Mar/2026
Boston Scientific USD 1.14B 3M Mar/2026
Cooper Companies USD 225.8M 74.6M Dec/2025
Dexcom USD 1.94B 109.1M Mar/2026
Edwards Lifesciences USD 181.1M 46.4M Mar/2026
Fresenius EUR 1.65B 564M Dec/2025
Globus Medical USD 103.66M 4.81M Mar/2026
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
ICU Medical USD 173.98M 19.61M Mar/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 149.8M 74.8M Mar/2026
Integra LifeSciences USD 87.95M 7.78M Mar/2026
Intuitive Surgical USD 1.85B 68.6M Mar/2026
J&J USD 10.46B 1.53B Mar/2026
Laboratory Of America USD 695.7M 145.1M Mar/2026
Masimo USD 89M 14M Mar/2026
Medtronic USD 2.57B 12M Dec/2025
Merit Medical Systems USD 67.85M 7.3M Mar/2026
Quest Diagnostics USD 1.5B 100M Mar/2026
Smith & Nephew USD 1.19B 73M Dec/2025
Stryker USD 1.8B 301M Dec/2025
Tandem Diabetes Care USD 59.86M 12.79M Mar/2026
Teleflex USD 143.63M 13.43M Mar/2026
Terumo JPY 97.49B 4.46B Dec/2025
Zimmer Biomet Holdings USD 361.2M 58.2M Mar/2026